Skip to main content
TipRanks
Go Ultimate75% OFF

Marvyn Harold Lubek Insider Profile

4 Followers

Marvyn Harold Lubek, Senior Officer at NexgenRx, holds 546.67K shares in NexgenRx (Ticker: TSE:NXG). Most recently, Marvyn Harold Lubek Bought 100,000 shares of NexgenRx on Nov 30, 2010 for an estimated value of C$29.00K.

Marvyn Harold Lubek's Trading History

NXG
NexgenRx
Nov 30, 2010Senior OfficerInformative Buy29.00KC$382.67K
TSE:NXG
Insider Shares: 546.67K (115.07%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Nov 30, 2010Informative BuyC$29.00K100,000C$0.29-14.00%―
Sep 30, 2010Informative BuyC$45.00K180,000C$0.25-14.20%―

You May Also Like

Marvyn Harold Lubek insider profile FAQ

What is the percentage of profitable transactions made by Marvyn Harold Lubek?
The percentage of profitable transactions made by Marvyn Harold Lubek is 0%.
What is the average return per transaction made by Marvyn Harold Lubek?
The average return per transaction made by Marvyn Harold Lubek is -14.10%.
What stocks does Marvyn Harold Lubek hold?
Marvyn Harold Lubek holds: TSE:NXG stocks.
What was Marvyn Harold Lubek’s latest transaction?
Marvyn Harold Lubek’s latest transaction was an Informative Buy of C$29.00K.
What was Marvyn Harold Lubek's most profitable transaction?
Marvyn Harold Lubek’s most profitable transaction was an Informative Buy of TSE:NXG stock on November 30, 2010. The return on the trade was -14.00%.
What is Marvyn Harold Lubek's role in NexgenRx?
Marvyn Harold Lubek's role in NexgenRx is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.